Overview

Our Story

Inception and Vision

PGxAI began with a simple yet profound question:

What if we could use genetics and AI to match every patient with the right medication at the right dose, the very first time?

Driven by this vision, our founding team—physicians, data scientists, and entrepreneurs—joined forces at an InterSystems incubator program. Their shared belief in the power of precision medicine laid the groundwork for the innovative solutions PGxAI delivers today.

Early Validation

From the start, we recognized that real-world data (RWD) and secure infrastructure would be crucial. Early grants from leading tech partners, like Google and Microsoft, helped shape our secure, HIPAA- and SOC 2–certified platform.

We then launched pilot programs with pioneering healthcare institutions to validate how generative AI could automate and enhance pharmacogenomic (PGx) insights.

Milestones & Growth

Serving every stakeholder in healthcare

Schedule a Demo Contact Us

First Commercial Pilot

Demonstrated how AI-driven PGx can reduce trial-and-error in oncology treatments by 25%.

Strategic Alliances

Expanded partnerships with health systems, CROs, labs, and payors, showing how seamlessly our platform scales.

Global Recognition

Attracted the attention of researchers, healthcare executives, and tech experts eager to leverage PGx for more effective, cost-efficient treatments.

Driving Innovation

As the industry evolves, so does PGxAI. We continuously refine our machine learning algorithms, integrate new biomarkers, and incorporate user feedback to keep our platform at the cutting edge.

Our approach blends scientific rigor with real-world practicality—empowering healthcare leaders to embrace AI-enabled decisions that improve patient care and reduce waste.

Future Outlook

Looking ahead, our mission remains unwavering

By weaving together AI, genomics, and clinical insight, PGxAI is not just transforming how medicine is prescribed—it’s reshaping the very fabric of modern healthcare, one patient at a time.

Expand Therapeutic Coverage

Broaden the spectrum of drugs and genes analyzed, ensuring maximum clinical impact.

Advance Global Collaboration

Know in advance which medications could trigger severe reactions.

Elevate Patient Experiences

Offer ever-more refined, intuitive, and secure solutions that place individual patient needs at the core.